These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure. Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811 [TBL] [Abstract][Full Text] [Related]
9. Intestinal ornithine decarboxylase in short bowel syndrome patients with oral diet. Segovia-Silvestre T; Pita AM; Vilar L; Venereo Y; Orta X; Farriol M Clin Nutr; 2001 Apr; 20(2):171-5. PubMed ID: 11327746 [TBL] [Abstract][Full Text] [Related]
10. Neonatal short bowel syndrome: a cohort study. Wales PW; de Silva N; Kim JH; Lecce L; Sandhu A; Moore AM J Pediatr Surg; 2005 May; 40(5):755-62. PubMed ID: 15937809 [TBL] [Abstract][Full Text] [Related]
11. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure. Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series. Ukleja A; To C; Alvarez A; Lara LF JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Disease and Short Bowel Syndrome. Fuglestad MA; Thompson JS Surg Clin North Am; 2019 Dec; 99(6):1209-1221. PubMed ID: 31676059 [TBL] [Abstract][Full Text] [Related]
14. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease. Schäffler H; Schneider N; Hsieh CJ; Reiner J; Nadalin S; Witte M; Königsrainer A; Blumenstock G; Lamprecht G Clin Nutr; 2013 Dec; 32(6):1029-35. PubMed ID: 23562557 [TBL] [Abstract][Full Text] [Related]
15. Parenteral nutrition: a life-saving intervention for 4 months in short bowel syndrome-a case report and review of the literature. Švagždys S; Smolskaitė I; Vindžigalskytė R J Med Case Rep; 2024 Mar; 18(1):122. PubMed ID: 38509559 [TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure. Pizzoferrato M; Puca P; Ennas S; Cammarota G; Guidi L World J Gastroenterol; 2022 Nov; 28(44):6258-6270. PubMed ID: 36504557 [TBL] [Abstract][Full Text] [Related]
17. Examining the pathophysiology of short bowel syndrome and glucagon-like peptide 2 analogue suitability in chronic intestinal failure: experience from a national intestinal failure unit. Bond A; Taylor M; Abraham A; Teubner A; Soop M; Carlson G; Lal S Eur J Clin Nutr; 2019 May; 73(5):751-756. PubMed ID: 30111847 [TBL] [Abstract][Full Text] [Related]
18. Necrotizing enterocolitis is associated with earlier achievement of enteral autonomy in children with short bowel syndrome. Sparks EA; Khan FA; Fisher JG; Fullerton BS; Hall A; Raphael BP; Duggan C; Modi BP; Jaksic T J Pediatr Surg; 2016 Jan; 51(1):92-5. PubMed ID: 26700691 [TBL] [Abstract][Full Text] [Related]